Indian Journal Watch: 30 October 2026

Indian Journal Watch, InfectionIndia.com

Indian Journal Watch

30 October 2026

Peer-reviewed microbiology, infectious disease, AMR and infection-control papers from India and South Asia, published or added to PubMed from 28 to 29 October 2026.

Lead articles

Vaccines & zoonoses · PLOS Medicine

Immunogenicity and safety of Institut Pasteur du Cambodge (IPC) and updated Thai Red Cross (UTRC) intradermal rabies vaccine regimens among healthy adults in India: A phase 4, open label, equivalence randomised controlled trial

PLOS Medicine · doi:10.1371/journal.pmed.1005079 · PubMed 42956084

What
A phase 4 equivalence randomised controlled trial from the ICMR National Institute of Epidemiology, Chennai, with ICMR National Institute of Virology, Pune, and MGMCRI, Pondicherry, comparing the 1-week intradermal Institut Pasteur du Cambodge (IPC) rabies post-exposure prophylaxis regimen with the 1-month updated Thai Red Cross (UTRC) regimen, using two vaccines widely used in India: PCECV and PVRV.
Design
Single-centre, open-label trial in healthy adult volunteers, block randomised 1:1:1:1 to IPC (Days 0, 3, 7) or UTRC (Days 0, 3, 7, 28) with either vaccine. The primary outcome was the geometric mean concentration ratio (GMR) of rabies virus neutralising antibody (RVNA) on day 42; equivalence was predefined as the entire 95% CI lying between 0.72 and 1.04. Registered as CTRI/2023/10/058418.
Key findings
Between 10 October and 23 December 2023, 400 participants were randomised (100 per group); 362 (90.5%) completed the regimen and day 42 blood draw. The day 42 GMR (IPC vs UTRC) was 0.59 (95% CI: 0.47-0.75) for PCECV and 0.76 (95% CI: 0.61-0.95) for PVRV, which did not meet the equivalence criterion. All participants had RVNA titres ≥0.5 IU/ml at every assessment from day 14 to 1 year. Adverse events were similar between regimens and mostly mild.
Limitations
Nearly one-quarter of participants had baseline RVNA titres ≥0.5 IU/mL despite exclusion of reported prior vaccination or dog bite. Participants were healthy volunteers rather than people receiving PEP after animal bites.
Relevance to India
The authors state that policy decisions on replacing UTRC should weigh these immunogenicity findings together with compliance, cost and vaccine availability.

Antimicrobial resistance · International Journal of Antimicrobial Agents

MCR-Mediated Colistin Resistance Across the One Health Continuum in South Asia: A Systematic Review and Meta-Analysis

International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.108051 · PubMed 42956909

What
A systematic review and meta-analysis, led from Pakistan, of mobilised colistin resistance (MCR) across human, animal, food and environmental sources in South Asia.
Design
PRISMA 2020, PROSPERO CRD420261414120. Five databases were searched without date restriction. Proportions were pooled with a random-effects binomial-normal GLMM (logit link), with a Freeman-Tukey/DerSimonian-Laird sensitivity analysis; subgroups by country, setting and publication period. Risk of bias used the JBI prevalence checklist.
Key findings
Thirty-four data points (7,407 isolates; 1,243 MCR-positive) from 31 studies in Pakistan, Bangladesh, Nepal and India were included. Pooled MCR prevalence was 14.70% (95% CI 13.37-16.13%; I² ≈ 97.8%), and 14.94% (95% CI 7.98-23.49%) in the sensitivity analysis. Bangladesh had the highest country-level prevalence (37.34%) and India the lowest (1.68%; 95% CI 0.98-2.86%). The animal and food compartment carried higher prevalence (35.69%) than the clinical (3.87%). mcr-1 was found in 31 of 34 data points (91%), and prevalence rose over successive publication periods (odds ratio 1.10 per year, 95% CI 1.06-1.15).
Limitations
Very high heterogeneity (I² ≈ 97.8%) and a modest number of studies, with uneven representation across countries and compartments.
Relevance to India
The authors call for coordinated One Health surveillance and regulatory action on colistin use in livestock across the region.

More from the journals

Antimicrobial resistance & stewardship

Vector-borne & zoonoses

IPC & healthcare-associated infection

Virology & vaccines

Diagnostics

Other

Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *